FXN and Friedreich ataxia: Clinically non-affected cells, such as FRDA patients-derived lymphocytes and fibroblasts, displayed milder changes in mitochondrial proteome and, interestingly, a much stronger downregulation of frataxin (Télot et al., 2018; Napierala et al., 2021).